Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients

OBJECTIVE: Limited evidence is available on predictors of medical resource utilization (MRU) and related direct costs, especially in treatment-experienced patients infected with genotype 1 hepatitis C virus (HCV). This study aimed at investigating patient and treatment characteristics that predict M...

Descripción completa

Detalles Bibliográficos
Autores principales: Akpo, Essè Ifèbi Hervé, Sbarigia, Urbano, Wan, George, Kleintjens, Joris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662942/
https://www.ncbi.nlm.nih.gov/pubmed/26416653
http://dx.doi.org/10.1007/s40268-015-0109-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662942/
https://www.ncbi.nlm.nih.gov/pubmed/26416653
http://dx.doi.org/10.1007/s40268-015-0109-5

Ejemplares similares